Project Description
The IBISC laboratory is involved in the new Instituts Hospitalo-Universitaires – IHU Prometheus, winners of the France 2030 plan’s call for IHU 3 projects! The IHU Prometheus is supported by Paris-Saclay University, Versailles Saint-Quentin-en-Yvelines University (UVSQ), CEA, AP-HP, Inserm and their academic, associative and industrial partners, and aims to reduce the mortality and sequelae caused by sepsis. The theme of the Promotheus IHU is: Precision medicine approaches to the therapeutic management of community-acquired and healthcare-associated sepsis.
In particular, research teams from the IBISC laboratory have been part of the 60 research teams involved in this large-scale project since its inception.
- Project start date: 05/2023
- IBISC members involved: Farida ZEHRAOUI (MCF Univ. Évry, IBISC team AROB@S), Dominique FOURER (MCF Univ. Évry, IBISC team SIAM), Vincent VIGNERON (PR Univ. Évry, IBISC team SIAM), Dro Désiré SIDIBÉ (PR IUT Évry, IBISC team SIAM)
- Press release of May 16, 2023, concerning the Prometheus IHU (PDF format)
- See the article on the UVSQ website: L’UVSQ engagé dans deux nouveaux IHU : Prometheus et Cancers des femmes
- See the AP-HP article of May 16, 2023: 7 IHU linked to AP-HP have been selected as part of the “Instituts Hospitalo-Universitaires – IHU 3” call for projects issued by the French National Research Agency.
- Web France 2030
Leave A Comment